Myocardial Infarction With No Obstructive Coronary Lesion

An adult has ischemic chest pain, dynamic electrocardiographic changes, and a rise and fall in cardiac troponin, yet angiography shows no stenosis of fifty percent or greater. The angiogram does not end the evaluation. MINOCA is a working framework that requires confirmation of infarction and exclusion of myocarditis, stress cardiomyopathy, pulmonary embolism, and overlooked coronary mechanisms.

Case focus#

The central decision is which tests can identify plaque disruption, spontaneous dissection, embolism, spasm, or microvascular dysfunction while also detecting nonischemic myocardial injury. Treating every person identically may expose some to harm, but withholding all secondary prevention while mechanism remains uncertain also carries risk.

This analysis concentrates on calibration. It compares plausible explanations, asks which observations genuinely discriminate among them, and keeps the working diagnosis open to revision as new evidence arrives.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this myocardial infarction with nonobstructive coronary arteries analysis, the working frame must remain broad enough to compare Plaque disruption with transient thrombosis, Spontaneous coronary artery dissection, Coronary vasospasm or microvascular dysfunction, Coronary embolism or thrombosis without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: A hospital cardiac service with acute coronary care, angiographic review, echocardiography, cardiac MRI, intracoronary imaging, and multidisciplinary follow-up.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Recurrent chest pain or dynamic ECG change: Ongoing ischemic symptoms, recurrent ST or T-wave change, or another troponin rise means coronary instability remains active despite nonobstructive angiography and requires monitored reassessment.
• Ventricular arrhythmia or hemodynamic instability: Sustained ventricular tachycardia, high-grade conduction disease, hypotension, shock, or resuscitated arrest raises concern for active ischemia, myocarditis, dissection, or mechanical complication.
• New heart failure or mechanical complication: Pulmonary edema, a new murmur, falling ejection fraction, ventricular septal defect, or pericardial effusion requires urgent echocardiographic and critical cardiac care.
• Angiographic concern for dissection or embolism: Long smooth narrowing, abrupt distal cutoff, dye staining, slow flow, or a thrombus without atherosclerotic explanation raises spontaneous dissection or embolism and changes antithrombotic and procedural choices.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Plaque disruption with transient thrombosis#

What supports it. An ischemic presentation with subendocardial infarction on MRI and intravascular ultrasound or optical coherence tomography showing rupture, erosion, or thrombus supports an atherosclerotic mechanism despite no severe residual stenosis.

What argues against it or keeps uncertainty open. Normal intracoronary imaging, no atherosclerotic features, and a nonischemic MRI pattern reduce plaque disruption, although timing can miss resolved thrombus.

Discriminating next step. Review angiography for subtle irregularity and use intracoronary imaging during or soon after the event when the result will change antiplatelet and prevention strategy.

Spontaneous coronary artery dissection#

What supports it. A younger or peripartum patient, emotional or physical stress, fibromuscular dysplasia, long smooth narrowing, distal tapering, or intramural hematoma supports spontaneous dissection.

What argues against it or keeps uncertainty open. Clear plaque rupture on intracoronary imaging or a focal embolic cutoff lowers this mechanism. Aggressive instrumentation itself can extend a dissection.

Discriminating next step. Obtain expert angiographic review and selective intracoronary imaging only when necessary and safe; screen associated arteriopathy according to current dissection guidance.

Coronary vasospasm or microvascular dysfunction#

What supports it. Rest pain with transient ST change, nitrate response, episodic pattern, nonobstructive arteries, or abnormal coronary flow and resistance testing supports epicardial spasm or microvascular ischemia.

What argues against it or keeps uncertainty open. A fixed focal infarct explained by plaque disruption or embolism and no recurrent vasomotor symptoms makes spasm less sufficient as the sole cause.

Discriminating next step. After acute stabilization, consider experienced-center provocative and microvascular functional testing when it can direct calcium-channel, nitrate, or other mechanism-specific treatment.

Coronary embolism or thrombosis#

What supports it. Atrial fibrillation, valve disease, endocarditis, intracardiac thrombus, paradoxical embolic route, hypercoagulability, or an abrupt distal angiographic cutoff supports embolic infarction.

What argues against it or keeps uncertainty open. No embolic source and direct evidence of local plaque or dissection lowers probability. Broad thrombophilia testing without context can generate misleading positives.

Discriminating next step. Use rhythm monitoring, echocardiography, valve and infection assessment, and selective thrombosis evaluation based on age, recurrence, and provoking factors.

Myocarditis or stress cardiomyopathy mimic#

What supports it. Viral prodrome, inflammatory symptoms, noncoronary MRI enhancement, edema, or a characteristic wall-motion pattern beyond one vascular territory can mimic myocardial infarction.

What argues against it or keeps uncertainty open. Subendocardial late enhancement in a coronary distribution and intracoronary evidence of plaque injury favor a true ischemic infarct.

Discriminating next step. Obtain early cardiac MRI with tissue characterization and review echocardiographic distribution; biopsy is reserved for severe presentations where histology changes treatment.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Confirm infarction criteria and review competing diagnoses. The case needs ischemic symptoms or ECG evidence plus a troponin rise and fall, while sepsis, pulmonary embolism, tachyarrhythmia, anemia, and kidney disease can produce myocardial injury without infarction. Interpretation: A coherent ischemic syndrome supports the MINOCA working diagnosis; a supply-demand process without acute coronary mechanism redirects to secondary myocardial injury.
• Expert second review of coronary angiography. Subtle dissection, distal occlusion, branch loss, thrombus, spasm, and overlooked moderate disease can be missed on the first urgent read. Interpretation: Reclassified obstruction ends the MINOCA pathway; long tapering supports dissection; an abrupt cutoff suggests embolism; truly smooth arteries prioritize MRI and functional mechanisms.
• Echocardiography for function and complications. Regional versus global wall motion, ejection fraction, valve disease, thrombus, shunt, right-heart strain, and pericardial fluid guide acute safety and the differential. Interpretation: A regional defect supports ischemia; a circumferential stress pattern or right strain redirects; intracardiac thrombus or valve lesion supports embolic evaluation.
• Early cardiac magnetic resonance imaging. Tissue edema and enhancement distribution distinguish infarction from myocarditis, stress cardiomyopathy, and some infiltrative disease, with highest yield when performed early. Interpretation: Subendocardial or transmural enhancement in a vascular territory confirms infarction; mid-wall or subepicardial enhancement supports myocarditis; edema without infarct can support stress cardiomyopathy.
• Selective intracoronary imaging or functional testing. Optical coherence tomography, intravascular ultrasound, vasospasm provocation, and microvascular measures are chosen from angiography, stability, and whether the result will alter treatment. Interpretation: Plaque disruption, intramural hematoma, inducible spasm, or abnormal microvascular resistance provides a mechanism. A negative test narrows but does not eliminate intermittent disease.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

Careful angiographic review raises concern for subtle distal vessel irregularity, while early cardiac MRI shows a subendocardial infarct pattern rather than myocarditis. Intracoronary imaging identifies plaque disruption without severe fixed narrowing. The mechanism changes the prevention plan and avoids an inaccurate label of noncardiac chest pain.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Continue acute coronary monitoring until instability resolves. Telemetry, repeat ECG and troponin, heart-failure assessment, and symptom control remain appropriate because a nonobstructive angiogram does not prevent arrhythmia or recurrent ischemia.
• Avoid one universal antithrombotic package. Plaque disruption may justify antiplatelet therapy, embolism may require anticoagulation, and spontaneous dissection or active bleeding may make aggressive antithrombotic treatment harmful. Therapy follows mechanism and bleeding risk.
• Use cause-directed secondary prevention. Lipid lowering, blood-pressure control, smoking cessation, vasospasm therapy, heart-failure treatment, and rehabilitation are selected from the identified process and overall cardiovascular risk.
• Protect against iatrogenic dissection harm. When spontaneous dissection is suspected and flow is stable, conservative management is often preferred; repeat instrumentation and stenting are reserved for ongoing ischemia or unstable anatomy.
• Preserve the diagnosis through follow-up. The discharge summary states confirmed myocardial injury, the working or final mechanism, pending MRI or functional testing, medication rationale, and who will revise therapy when results arrive.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain that the heart injury is genuine even though no major fixed blockage was seen, and that the term MINOCA names an investigation stage rather than one disease. Review why MRI or vessel imaging matters and separate established treatment from mechanism-dependent options.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Return urgently for recurrent pressure, fainting, palpitations, new breathlessness, focal neurologic symptoms, or a rapid decline in exercise tolerance.
• Review medication purpose after the mechanism is clarified so antiplatelet, anticoagulant, vasodilator, and heart-failure therapy are not continued or stopped by inertia.
• Complete cardiac MRI and any planned vessel or embolic-source assessment within the stated interval, with direct communication of results.
• Enroll in rehabilitation and reassess symptoms, ventricular function, blood pressure, lipids, rhythm, and psychosocial recovery after the acute event.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Women and younger adults with nonobstructive angiograms may have symptoms dismissed, while advanced imaging access varies substantially. Preserve the infarction diagnosis during handoff, arrange timely testing, use financial navigation, and do not let a normal-looking angiogram erase rehabilitation or risk-factor care.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Treats MINOCA as a working diagnosis that requires a mechanism rather than a reassuring angiographic endpoint.
• Distinguishes infarction from myocardial injury and nonischemic mimics using clinical criteria and cardiac MRI.
• Recognizes subtle plaque, dissection, embolic, spasm, and microvascular patterns and selects invasive tests proportionately.
• Matches antithrombotic and prevention therapy to mechanism rather than applying an obstructive-coronary template.
• Protects the diagnosis and pending-test plan during discharge so objective heart injury is not later dismissed as noncardiac.

Key takeaways#

• No obstructive lesion does not mean no infarction, no risk, or no need for cardiac rehabilitation.
• Early MRI and expert angiographic review often determine whether treatment should target plaque, dissection, embolism, spasm, microvascular disease, or a mimic.
• Mechanism matters because the same antithrombotic approach can help one MINOCA cause and harm another.